BMC Cancer Oncology

CombiCoR-Vax trial: study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cancer

Alessandro Passardi, Francesco Giulio Sullo, Alessandro Bittoni, Laura Matteucci, Francesco De Rosa, Jenny Bulgarelli, Marcella Tazzari, Massimiliano Petrini, Emanuela Scarpi, Sara Testoni, Anna Miserocchi, Ottavia Tartagni, Chiara Zani, Maria Laura Iaia, Ilaria Toma, Massimo Giuseppe Viola, Maria Teresa Mita, Emiliano Tamburini, Laura Ridolfi
Springer Nature · 2025-11-22 · DOI 10.1186/s12885-025-15371-7

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →